Danahy Kevin Patrick's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Oct 3, 2022
- Accession no.
- 0001839882-22-022698
- Filed
- Oct 3, 2022
- Trade date
- Sep 30, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $14.9K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Danahy Kevin PatrickCIK 0001913245 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2022 | Common Stock | PPurchaseAcquired | +6,500 | $2.30F1 | +$14,950 | 6,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This purchase price represents the weighted average purchase price of the shares purchased on September 30, 2022, ranging from $2.28 to $2.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.